September 30, 2016 11:20 AM ET

Biotechnology

Company Overview of Kosan Biosciences Incorporated

Key Executives for Kosan Biosciences Incorporated

NameBoard RelationshipsTitleAge
Pamela S. Cohen M.D.No RelationshipsChief Medical Officer and Senior Vice President--

Kosan Biosciences Incorporated Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Davis Ph.D. 15 RelationshipsBionova Holding Corporation71
Charles J. Homcy M.D. 89 RelationshipsGlobal Blood Therapeutics, Inc.68
Haruo Seto Ph.D. 9 RelationshipsKosan Biosciences Incorporated--
Mohamed A. Marahiel Ph.D. 9 RelationshipsKosan Biosciences Incorporated--
Ivan M. Kompis Ph.D. 9 RelationshipsKosan Biosciences Incorporated--
View All Board Members

Kosan Biosciences Incorporated Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Ph.D.Peter Davis15 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.1K
Bonus
264.0K
Total Short Term Compensation
478.4K
Total Value of Options
32.9M
Compensation as of Fiscal Year
Kosan Biosciences Incorporated CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Medibio Limited Announces Resignation of James Campbell as Non-Executive Director
September 30, 2016 3:22 AM ET
Threshold Pharmaceuticals Inc. to Implement Workforce Reduction; Announces Resignation of Stewart Kroll as Chief Operating Officer
September 29, 2016 9:20 PM ET
Kite Pharma, Inc. Appoints Christine Cassiano as Senior Vice President of Corporate Communications and Investor Relations
September 29, 2016 8:05 PM ET
Diffusion Pharmaceuticals Inc. Announces Establishment of New Scientific Advisory Board
September 29, 2016 2:05 PM ET
Flexion Therapeutics, Inc. Announces Appointment of John Magee as Vice President of Sales
September 29, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kosan Biosciences Incorporated, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.